Objective: To investigate the controllable risk factors of dyslipidemia in middle-aged women under different menopausal status and to propose preventive strategies. Methods: A total of 1 011 women aged 40-60 who were enrolled in the First Affiliated Hospital of Harbin Medical University from January 2018 to January 2019 were included. The diet was assessed using questionnaire. Physical measurement and biochemical detection were also performed. According to the status of menopause, women were divided into premenopausal, perimenopausal and postmenopausal groups. The differences of lifestyle, dietary intake, chronic diseases and metabolic indexes in middle-aged women with different menopausal status were compared. According to the level of blood lipid, the controllable risk factors associated with dyslipidemia in women with different menopausal status were analyzed by Logistic regression among the above different indicators. Results: There were significant differences in economic status, lifestyle (alcohol consumption, sleep status), chronic diseases (dyslipidemia, hypertension, coronary heart disease, cerebral infarction, lower limb plaques), dietary intake (nut intake, eating speed), the levels of biochemical indicators (low density lipoprotein, high density lipoprotein, total cholesterol, creatinine and urea nitrogen) (P<0.05). Body mass index was a risk factor for dyslipidemia in premenopause and perimenopause.(OR=1.237, 95%CI:1.091-1.401, P<0.05; OR=1.218, 95%CI:1.103-1.346, P<0.05). Better economic status, occasional alcohol consumption and uric acid levels were risk factors for dyslipidemia in postmenopausal women(OR=3.785, 95%CI:1.240-11.554, P<0.05; OR=4.372,95%CI:1.281-14.924, P<0.05; OR=1.003, 95%CI:1.000-1.006); while the protective factors for dyslipidemia were normal vegetable intakes, sleeping time longer than 7 hours, and fasting blood glucose levels(OR=0.310, 95% CI:0.142-0.677, P<0.05; OR=0.457,95% CI:0.268-0.781, P<0.05; OR=0.894, 95%CI:0.830-0.964, P<0.05). Conclusion: Controllable risk factors including body mass index, lifestyle and dietary intake may have an impact on the blood lipid levels in middle-aged women under different menopausal status. |
[1] TAKAHASHI T A, JOHNSON K M.Menopause[J]. Med Clin North Am, 2015, 99(3):521-534.
[2] SAHA K R, RAHMAN M M, PAUL A R, et al. Changes in lipid-profile of postmenopausal women[J]. Mymensingh Med, 2013, 22(4):706-711.
[3] ATSMA F, BARTELINK M L, GROBBEE D E, et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease:a meta-analysis[J]. Menopause, 2006, 13(2):265-279.
[4] JASPERS L, DAAN N M, DIJK G M, et al. Health in middle-aged and elderly women:a conceptual framework for healthy menopause[J]. Maturitas, 2015, 81(1):93-98.
[5] 中国医师协会心血管内科医师分会女医师工作委员会, 中华医学会心血管病学分会女性心脏健康学组.绝经后女性血脂异常管理的中国专家共识[J]. 中华内科杂志, 2017, 56(6):472-476.
[6] SCHNEIDER H, BIRKHAUSER M.Quality of life in climacteric women[J]. Climacteric, 2017, 20(3):187-194.
[7] LI L, WU J, PU D, et al. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women[J]. Maturitas, 2012, 73(4):354-360.
[8] TSENG L A, EL K S, YOUNG E A, et al. The association of menopause status with physical function:the study of women's health across the nation[J]. Menopause, 2012, 19(11):1186-1192.
[9] MARCHAND G B, CARREAU A M, WEISNAGEL S J, et al. Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women[J]. Physiol Endocrinol Metab, 2018, 314(5):E448-E456.
[10] BABER R J, PANAY N, FENTON A, et al. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy[J]. Climacteric, 2016, 19(2):109-150.
[11] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2016, 44(10):833-853.
[12] 曾伟, 黄晓波, 贾勇, 等.绝经后女性血脂异常管理的中国专家共识[J]. 中国公共卫生杂志, 2010, 26(9):1095-1097.
[13] ZHOU J L, LIN S Q, SHEN Y, et al. Serum lipid profile changes during the menopausal transitionin Chinese women:A community-based cohort study[J]. Menopause, 2010, 17(5):997-1003.
[14] CHOI Y, CHANG Y, KIM B K, et al. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women[J]. Maturitas, 2015, 80(4):399-405.
[15] AURO K, JOENSUU A, FISCHER K, et al. A metabolic view on menopause and ageing[J]. Nat Commun, 2014, 5:4708.
[16] KIM B, FELDMAN E L.Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome[J]. Exp Mol Med, 2015, 47(3):e149.
[17] WASKIEWICZ A, SYGNOWSKA E.Alcohol intake and cardiovascular risk factor profile in men participating in the WOBASZ study[J]. Kardiol Pol, 2013, 71(4):359-365.
[18] KALLA A, FIGUEREDO V M.Alcohol and cardiovascular disease in the geriatric population[J]. Clin Cardiol, 2017, 40(7):444-449.
[19] HIGASHIYAMA A, OKAMURA T, WATANABE M, et al. Alcohol consumption and cardiovascular disease incidence in men with and without hypertension:the suita study[J]. Hypertens Res, 2013, 36(1):58-64.
[20] SHEN Z, MUNKER S, WANG C, et al. Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia[J]. Clin Lipidol, 2014, 8(3):273-278.
[21] KWON Y J, KIM S E, PARK B J, et al. High-risk drinking is associated with dyslipidemia in a different way, based on the 2010-2012 KNHANES[J]. Clin Chim Acta, 2016, 456(5):170-175.
[22] KECHAGIAS S, ZANJANI S, GJELLAN S, et al. Effects of moderate red wine consumption on liver fat and blood lipids:a prospective randomized study[J]. Ann Med, 2011, 43(7):545-554.
[23] LAMPIO L, SAAREAEANTA T, ENGBLOM J, et al. Predictors of sleep disturbance in menopausal transition[J]. Maturitas, 2016, 94(10):137-142.
[24] MILLER M A, KRUISBRINK M, WALLACE J, et al. Sleep duration and incidence of obesity in infants, children, and adolescents:a systematic review and meta-analysis of prospective studies[J]. Sleep, 2018, 41(4):1-18.
[25] RUIZ-CABELLO P, COLL-RISCO I, ACOSTA-MANZANO P, et al. Influence of the degree of adherence to the Mediterranean diet on the cardiometabolic risk in peri and menopausal women[J]. Nutr Metab Cardiovasc Dis, 2017, 27(3):217-224.
[26] CHO Y A, KIM J, CHO E R, et al. Dietary patterns and the prevalence of metabolic syndrome in Korean women[J]. Nutr Metab Cardiovasc Dis, 2011, 21(11):893-900.
[27] KAHLEOVA H, SALAS-SALVADO J, RAHELIC D, et al. Dietary patterns and cardiometabolic outcomes in diabetes:a summary of systematic reviews and meta-analyses[J]. Nutrients, 2019, 11(9):2209.
[28] NIH State-of-the-Science Conference Statement on management of menopause-related symptoms[J]. NIH Consens State Sci Statements, 2005, 22(1):1-38. |